Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Horizons Psychedelic Stock Index ETF HPSYF

Consumer Cyclical
PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index (the Underlying Index, Bloomberg ticker: HPSYKTR), net of expenses. The ETF will not seek to hedge any foreign currency exposure To achieve the ETFs investment objective, the ETF invests and holds equity securities of the Constituent Issuers in substantially the same proportion as the current Underlying Index. To the extent permitted, the ETF will generally be fully invested in or exposed to the Underlying Index at all times and will have substantial exposure to the North American psychedelics industry.


GREY:HPSYF - Post by User

Horizons Psychedelic Stock Index ETF
Bullboard Posts
Next >>
User Avatar Image
(273)
•••
Post by partystockeron Nov 23, 2021 3:35pm
91 Views
Post# 34158546

$PSYK Competitor $ORIG to IPO This Quarter

$PSYK Competitor $ORIG to IPO This Quarter

The more I read about Origin Therapeutics the more excited I am for them to go public. Through a portfolio including both private and public companies, it’s going to give retail investors a chance to gain exposure to companies in the psychedelic field that would normally only be accessible to venture capitalists. 


Their portfolio is quite diverse ranging from businesses involved in the promotion of psychedelics to clinics and manufacturers. They also offer 0% fees unlike a lot of funds. 


We can expect Origin to be traded publicly on the CSE this quarter under $ORIG.C. I recommend checking out the investor presentation to get more info about their operations.  


https://originpsychedelics.com/wp-content/uploads/2021/11/Origin-Presentation-V28.pdf

 
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities